Oncology & Cancer

Polio-rhinovirus promising for malignant glioma patients

(HealthDay)—Intratumoral infusion of recombinant nonpathogenic polio-rhinovirus chimera (PVSRIPO) can be delivered safely and is tied to higher survival rates than those of historical controls, according to a study published ...

page 9 from 17